Cullgen raises $15M seed round

Cullgen Inc. (San Diego, Calif.) said it raised $15 million on March 1 in seed funding from GNI Group Ltd. The company is building a drug discovery platform based on ubiquitin-mediated protein degradation technology that will initially focus on cancer and potentially expand into inflammatory and autoimmune diseases...